Clinical Trials Browser

Phase 3 × Mitoxantrone × 30 days × Clear all

NCT02101853 2026-06-03

Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia

Phase 3 Active not recruiting

669 enrolled 14 charts

Burkitt Lymphoma

NCT01371981 2026-06-02

Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Phase 3 Completed

1,645 enrolled 32 charts

Other hematologic neoplasmSarcoma

Leukemia, Myeloid, Acute, Sarcoma, Myeloid

NCT02688140 2026-05-29

TUD-APOLLO-064

Phase 3 Completed

Other hematologic neoplasm

Leukemia, Promyelocytic, Acute